Search clinical trials for: famitinib malate T(5 mg*4)、famitinib malate R(20 mg)
Total 60 results
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ruijin HospitalNot yet recruiting
-
Canadian Heart Research CentreGlaxoSmithKlineCompletedType 2 Diabetes MellitusCanada
-
GlaxoSmithKlineCompleted
-
Lynkcell EuropeAvailableKidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Healthcare PharmaceuticalsRecruitingSpondyloarthritis, AxialBangladesh
-
LG Life SciencesCompletedHypertension | HyperlipidemiaKorea, Republic of
-
Center Trials & TreatmentWithdrawnGliosarcoma | Recurrent Glioblastoma | Anaplastic GliomasSingapore, Hong Kong
-
Alexza Pharmaceuticals, Inc.Atlanta Center for Medical ResearchCompleted
-
Omar Tarek ElfarargiNot yet recruiting
-
Woman'sBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedPolycystic Ovary SyndromeUnited States
-
Teva Neuroscience, Inc.Completed
-
Abramson Cancer Center at Penn MedicinePfizerTerminatedColorectal Neoplasms MalignantUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR)CompletedPregnancy Complications | PreeclampsiaCanada, United Kingdom, Argentina, Australia, Jamaica
-
GlaxoSmithKlineCompleted
-
Duke UniversityMerck Sharp & Dohme LLCCompletedMajor Depressive Disorder Without Psychotic FeaturesUnited States
-
PfizerCompletedMenopause | OsteoporosisUnited States, Colombia, Australia, Hungary, Poland, Finland, Argentina, Chile, Denmark, Mexico, New Zealand, Norway
-
Hal ChapmanMassachusetts General Hospital; University of Michigan; University of Washington and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
MallinckrodtCompleted
-
University Hospital, Basel, SwitzerlandRecruiting
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Sephoris Pharmaceuticals LLCTerminated
-
Mylan Pharmaceuticals IncCompleted
-
Future University in EgyptCompletedHealthy SubjectsEgypt
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
University of Texas Southwestern Medical CenterNational Center for Research Resources (NCRR)CompletedPulmonary Arterial HypertensionUnited States
-
Afyon Kocatepe University HospitalCompleted
-
Tyumen State Medical AcademyUnknownHyperandrogenism | Polycystic Ovarian Syndrome | Menstrual IrregularitiesRussian Federation
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Chengdu PLA General HospitalUnknownRheumatoid ArthritisChina
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Klinički Bolnički Centar ZagrebUniversity of ZagrebRecruitingOcular Hypertension | Primary Open-angle GlaucomaCroatia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
CardresearchMcMaster University; Eiger BioPharmaceuticals; Cytel Inc.; Fastgrants; RainWater...RecruitingCovid19 | SARS-Associated CoronavirusBrazil
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Center for International Blood and Marrow Transplant...National Marrow Donor ProgramCompletedChronic Lymphocytic Leukemia (CLL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chemotherapy-sensitive Lymphoma | Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma | Acute Biphenotypic Leukemia (ABL) | Acute Undifferentiated Leukemia (AUL)United States
-
Fred Hutchinson Cancer CenterCompletedMyelodysplastic Syndrome (MDS) | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Blasts Under 5 Percent of Bone Marrow...United States
-
Ain Shams UniversityUnknown
-
CM Chungmu HospitalKorea United Pharm. Inc.UnknownNausea | VomitingKorea, Republic of
-
Ain Shams UniversityRecruitingUterine LeiomyomaEgypt
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedPancreatic Adenocarcinoma | Unresectable Pancreatic Carcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedNon-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Yang I. PachankisCompletedRenal Dialysis | Vaccines | Infection Viral | Severe Acute Respiratory Syndrome-related Coronavirus | Myocarditis AllergicChina
-
Children's Oncology GroupNational Cancer Institute (NCI); ImmunoGen, Inc.WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent...
-
M.D. Anderson Cancer CenterCompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States